Generic Name: Saxagliptin
Brand Name: Onglyza
Manufacturer: Bristol-Myers Squibb / AstraZeneca Canada Inc.
Therapeutic Area: Diabetes mellitus, type 2
Indications: Diabetes mellitus (Type 2)
Submission Type: Resubmission
Project Status: Withdrawn
CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.
Generic Name: Saxagliptin
Brand Name: Onglyza
Manufacturer: Bristol-Myers Squibb / AstraZeneca Canada Inc.
Therapeutic Area: Diabetes mellitus, type 2
Indications: Diabetes mellitus (Type 2)
Submission Type: Resubmission
Project Status: Withdrawn